DEFINITIVE PROXY STATEMENT

Company

Ernexa Therapeutics Inc.

Filed

June 7, 2001

Period of Report

June 29, 2001

Accession Number

0001035704-01-500164

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →